Op-eds
Spectrum auction authority must be extended
To achieve the socio-economic benefits that 5G and other new technologies will bring, the FCC must be enabled to create a balanced spectrum pipeline.
Drug importation is dangerous and won’t lower prices
Competition and innovation lead to lower prices, not government pricing schemes.
Interest on the debt is a huge threat
President Biden and Congress need to stop spending and start cutting before it becomes too late to stop interest on the debt from growing to become the government’s largest expenditure.
Let's Keep Driving Forward on Connected Cars & Next-Gen Wi-Fi
These days, there isn’t a lot of harmony in the world of technology policy. But there is a bright spot of bipartisanship in a section of our airwaves: the 5.9 GHz band.
Taxpayers should not be forced to fund professional stadiums
Government funding of professional sports stadiums through tax-exempt bonds also reduces the resources available for more pressing local projects.
Taking a day to celebrate innovation and intellectual property rights
Encouraging young people to participate in the innovation economy is a laudable and necessary objective, as well as ensuing that they understand the importance of protecting IP rights.
Opinion: Georgia healthcare legislation would increase drug costs
Legislators in several states, including Georgia, are attempting to lower prescription drug prices by regulating PBMs.
COVID-19 relief funding programs lack oversight and accountability
Congress has appropriated more than $4.6 trillion in response to COVID-19, much of which has nothing to do with the pandemic.
Commentary: Lenoir City Taxpayers Can Stop a Wasteful Broadband Network
Lenoir City taxpayers have a chance to save themselves from an expensive and wasteful broadband network proposal, but they have to act soon.
The new era of American aerospace
Competition in all areas of aerospace contracting represents a rare procurement triumph for the federal government.
Fiscal conservatives should support postal reform
The USPS has been the subject of a significant amount of justifiable criticism for many years.
Viewpoint: Eliminate the red tape that stifles drug benefits
The mounting debate over prescription drug prices has led several states, including Oklahoma, to over-regulate PBMs.
